An Observational Study of Patients With Chronic Liver Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

500000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-19

Study Completion Date

2037-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Integrated Approaches for Identifying Molecular Targets in Liver Disease

NCT03915002

Alcoholic Liver Disease Non-Alcoholic Fatty Liver Disease Steatohepatitis, Nonalcoholic +1 more

COMPLETED

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

NCT02815891

Nonalcoholic Fatty Liver Nonalcoholic Steatohepatitis

RECRUITING

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

NCT03193151

Liver Dysfunction

RECRUITING

Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After Optimization

NCT04571957

Non Alcoholic Steatohepatitis

COMPLETED

Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH

NCT05357248

Non-alcoholic Steatohepatitis Non-Alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Liver Disease Cirrhosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Disease Cohort

Observational

Intervention Type OTHER

Observational

Engaged Cohort

Observational

Intervention Type OTHER

Observational

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Disease Cohort

•Adult\* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface

Engaged Cohort

* Adult\* patients diagnosed and managed for CLD/cirrhosis invited to participate
* Ability to provide written informed consent

Exclusion Criteria

Disease Cohort

* Death
* Manual removal (sponsor or site request)
* No EHR interface encounter \> 3 years.

Engaged Cohort

* Patient expressed desire to withdraw consent to complete PROs
* Failure to complete PROs within 24 weeks of initial invitation
* Greater than 24 months lapse of survey completion after baseline surveys completed
* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No